155 related articles for article (PubMed ID: 36830609)
1. Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases.
Abdulla M; Sundström C; Lindskog C; Hollander P
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830609
[TBL] [Abstract][Full Text] [Related]
2. Patients with autoimmune diseases have an altered activity of the PD-1 pathway and proportions of Epstein-Barr virus infected cells in benign lymphadenopathies.
Sundström C; Hollander P
Immunobiology; 2021 Mar; 226(2):152069. PubMed ID: 33581582
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.
Abdulla M; Alexsson A; Sundström C; Ladenvall C; Mansouri L; Lindskog C; Berglund M; Cavelier L; Enblad G; Hollander P; Amini RM
Acta Oncol; 2021 Apr; 60(4):531-538. PubMed ID: 33579170
[TBL] [Abstract][Full Text] [Related]
4. Distribution of Epstein-Barr virus in systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis) with associated lymphadenopathy: a study of 49 cases.
Kojima M; Motoori T; Itoh H; Shimizu K; Iijima M; Tamaki Y; Murayama K; Ohno Y; Yoshida K; Masawa N; Nakamura S
Int J Surg Pathol; 2005 Jul; 13(3):273-8. PubMed ID: 16086083
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease.
Takeuchi M; Sato Y; Yasui H; Ozawa H; Ohno K; Takata K; Gion Y; Orita Y; Tachibana T; Itoh T; Asano N; Nakamura S; Swerdlow SH; Yoshino T
Am J Surg Pathol; 2014 Jul; 38(7):946-55. PubMed ID: 24705309
[TBL] [Abstract][Full Text] [Related]
6. Histological varieties of Epstein-Barr virus-related lymph node lesion resembling autoimmune disease-like clinicopathological findings in middle-aged and elderly patients: a study of six cases.
Kojima M; Sugiura I; Itoh H; Shimizu K; Murayama K; Motoori T; Shimano S; Masawa N; Nakamura S
Pathol Res Pract; 2006; 202(8):609-15. PubMed ID: 16824704
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-related lymph node lesion resembling autoimmune disease-like clinicopathological findings in elderly patients. Report of three cases.
Kojima M; Yamane Y; Itoh H; Tanaka H; Sugihara S; Masawa N; Nakamura S
APMIS; 2003 Dec; 111(12):1083-8. PubMed ID: 14678016
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of EBV-infected cells in HIV-related lymphadenopathy: implications for the pathogenesis of EBV-associated and EBV-unrelated lymphomas of HIV-seropositive individuals.
Dolcetti R; Gloghini A; De Vita S; Vaccher E; De Re V; Tirelli U; Carbone A; Boiocchi M
Int J Cancer; 1995 Nov; 63(5):652-9. PubMed ID: 7591281
[TBL] [Abstract][Full Text] [Related]
9. Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype.
Takada K; Toyokawa G; Kinoshita F; Jogo T; Kohashi K; Wakasu S; Ono Y; Tanaka K; Oba T; Osoegawa A; Tagawa T; Azuma K; Okamoto I; Shimokawa M; Oda Y; Mori M
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2639-2650. PubMed ID: 32405745
[TBL] [Abstract][Full Text] [Related]
10. EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.
Cristino AS; Nourse J; West RA; Sabdia MB; Law SC; Gunawardana J; Vari F; Mujaj S; Thillaiyampalam G; Snell C; Gough M; Keane C; Gandhi MK
Blood; 2019 Dec; 134(25):2261-2270. PubMed ID: 31856276
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic features of systemic EBV-positive T/NK-cell lymphoproliferative disease in adults].
Zheng XD; Zhou XG; Jin Y; Xie JL; Wei XJ; Chen SY; Mei X; Gong LP; Lü BB
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):227-34. PubMed ID: 21615995
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features of angioimmunoblastic T-cell lymphoma pattern Ⅰ].
Lu HD; Xie JL; Zhang LN; Zheng YY; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):856-860. PubMed ID: 36097902
[No Abstract] [Full Text] [Related]
13. Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with Epstein-Barr virus, PD-L1 copy number alterations, and outcome.
Veloza L; Teixido C; Castrejon N; Climent F; Carrió A; Marginet M; Soldini D; González-Farré B; Ribera-Cortada I; Lopez-Guillermo A; González-Barca E; Sierra A; Herrera M; Gómez C; Garcia A; Balagué O; Campo E; Martinez A
Histopathology; 2019 Dec; 75(6):799-812. PubMed ID: 30861172
[TBL] [Abstract][Full Text] [Related]
14. Precursor cells and implications of a T-cell inflamed immune response in the pre-malignant setting in Hodgkin lymphoma.
Hollander P; Ginman B; Molin D; Enblad G; Amini RM; Glimelius I
Immunobiology; 2020 Jan; 225(1):151872. PubMed ID: 31787352
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
Dong M; Wang HY; Zhao XX; Chen JN; Zhang YW; Huang Y; Xue L; Li HG; Du H; Wu XY; Shao CK
Hum Pathol; 2016 Jul; 53():25-34. PubMed ID: 26980034
[TBL] [Abstract][Full Text] [Related]
16. Enhanced PD-L1 Expression in LMP1-positive Cells of Epstein-Barr Virus-associated Malignant Lymphomas and Lymphoproliferative Disorders: A Single-cell Resolution Analysis With Multiplex Fluorescence Immunohistochemistry and In Situ Hybridization.
Kume A; Shinozaki-Ushiku A; Kunita A; Kondo A; Ushiku T
Am J Surg Pathol; 2022 Oct; 46(10):1386-1396. PubMed ID: 35605962
[TBL] [Abstract][Full Text] [Related]
17. Determination of Epstein-Barr virus association with B-cell lymphomas in Japan: study of 72 cases--in situ hybridization, polymerase chain reaction, immunohistochemical studies.
Hirose Y; Masaki Y; Sasaki K; Ogawa Y; Takeshita S; Fukutoku M; Sugai S; Takiguchi T
Int J Hematol; 1998 Feb; 67(2):165-74. PubMed ID: 9631583
[TBL] [Abstract][Full Text] [Related]
18. Epstein Barr Virus Infection Can be a Secondary Event in B-Cell Lymphomas: A Review of 338 Cases and a Novel Finding of Zonal EBER+ Tumor Cells Showing Features of Progression From Underlying EBV-negative Lymphoma.
Miller IJ
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):165-173. PubMed ID: 28800008
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) antigens and genome in lymph nodes of HIV-positive patients affected by persistent generalized lymphadenopathy (PGL).
Uccini S; Monardo F; Vitolo D; Faggioni A; Gradilone A; Aglianó AM; Manzari V; Ruco LP; Baroni CD
Am J Clin Pathol; 1989 Dec; 92(6):729-35. PubMed ID: 2556016
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma.
Shibata D; Weiss LM; Nathwani BN; Brynes RK; Levine AM
Blood; 1991 Apr; 77(7):1527-33. PubMed ID: 1849034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
